Аntithrombotic prophylaxis and therapy in oncology
In the article the authors revise a number of methods used in clinic for the description of hypercoagulation syndrome and consider that persistent trombinemia signs and signs of platelet hyperaggregation with the increased consumption of them are the most reliable markers of hypercoagulation and pre...
Saved in:
| Main Authors: | Z. S. Barkagan, A. N. Shilova, S. A. Khodorenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Siberian State Medical University (Tomsk)
2003-09-01
|
| Series: | Бюллетень сибирской медицины |
| Subjects: | |
| Online Access: | https://bulletin.ssmu.ru/jour/article/view/3796 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Homocysteine, cancer and oncothrombosis
by: V. O. Bitsadze, et al.
Published: (2023-09-01) -
Hypercoagulability and COVID-19 Infection
by: Alciona SASU, et al.
Published: (2025-06-01) -
ЗАБЕЗПЕЧЕННЯ ІНТРАОПЕРАЦІЙНОГО ГЕМОСТАЗУ ПРИ РЕВАСКУЛЯРИЗУЮЧИХ ВТРУЧАННЯХ
by: І. К. Venger, et al.
Published: (2017-07-01) -
Prevention of thrombotic complications in patients with AL amyloidosis
by: V. A. Khyshova, et al.
Published: (2023-12-01) -
The assesment of prothrombotic potential using thrombin generation assay in pediatric patients with nephrotic syndrome: preliminary study
by: Eren Soyaltın, et al.
Published: (2021-04-01)